CANY
EXAS

Caxton Associates (New York)’s Exact Sciences EXAS Stock Holding History

Caxton Associates (New York)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,281
Closed -$269K – 434
2019
Q2 		$269K Buy
+2,281
New +$230K 0.03% 307

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Caxton Associates (New York)'s EXAS Position: Q3 2019 in Review

Caxton Associates (New York) sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 2,281 shares — an estimated $269K sold.

Caxton Associates (New York) first reported a position in EXAS in Q2 2019 and held it in 1 quarter. The position peaked at $269K in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Caxton Associates (New York) reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,281 Exact Sciences shares in Q3 2019, an estimated $269K.
  • Caxton Associates (New York) first reported a position in Exact Sciences in Q2 2019 and held it in 1 quarter.
  • Caxton Associates (New York)'s Exact Sciences position peaked at $269K in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Caxton Associates (New York)'s 13F filing for Q3 2019, filed 14 Nov 2019.